GWAS |
- Antidepressant treatment resistance (> 2 drugs prescribed) ( 30700811)
- Blood protein levels ( 30072576)
- Body mass index ( 26426971)
- Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) ( 26252872)
- Dementia and core Alzheimer's disease neuropathologic changes ( 25188341)
- Metabolite levels (X-11787) ( 23934736)
- Motion sickness ( 25628336)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Pneumoconiosis in silica exposure ( 24986923)
- Protein quantitative trait loci ( 18464913)
|
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis ( 30926877)
- Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis ( 30926877)
- Anxiety disorder ( 25390645)
- Asthma ( 29273806)
- Blood protein levels ( 30072576)
- Body fat mass ( 28552196)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Heart rate ( 23534349)
- Initial pursuit acceleration ( 29064472)
- Male-pattern baldness ( 27182965)
- Mosquito bite size ( 28199695)
- Obesity-related traits ( 23251661)
- Positive urgency ( 30718321)
- Retinal venular tortuosity ( 31597446)
- Schizophrenia (inflammation and infection response interaction) ( 25781172)
- Sleep (1/2-day periodicity) ( 33075057)
- Triglyceride levels ( 34074324)
- Trunk fat mass ( 28552196)
- Type 2 diabetes (age of onset) ( 28060188)
|